Photoacoustic imaging (PAI) is a noninvasive hybrid imaging modality offering rich optical contrast and high depth-to-resolution ratio deep-tissue imaging. Endogenous chromophores present in the body such as hemoglobin, lipid, melanin, and so on provide strong photoacoustic contrast due to their strong light absorption in certain optical window. To enhance the performance of PAI further, researchers have developed several exogenous contrast agents such as metallic nanoparticles, carbon-based nanomaterials, quantum dots, organic small molecules, semiconducting polymer nanoparticles, and so on. These exogenous contrast agents not only help improving the imaging contrast, but also make targeted molecular imaging possible. In this review article, we first discuss the state-of-the-art PAI techniques with endogenous contrast mechanism. Later, we provide an overview of recent progress in the development of exogenous photoacoustic contrast agents for in vivo imaging applications. Finally, we present the pros/cons of the existing PA contrast agents along with future challenges of contrast agent-based PAI for biomedical applications.
surface. Upon absorption of light by the tissue chromophores, it undergoes a time-varying thermal expansionrelaxation process, which leads to the generation of ultrasound waves (known as photoacoustic [PA] waves) in the tissue. The generated PA waves are collected at the tissue surface and the absorption maps within the tissue are obtained using various image reconstruction techniques (Gutta et al., 2017; C. Huang, Wang, Nie, Wang, & Anastasio, 2013; H. Huang, Bustamante, Peterson, & Ye, 2015; Prakash, Sanny, Kalva, Pramanik, & Yalavarthy, 2019; Schoeder, Olefir, Kronbichler, Ntziachristos, & Wall, 2018; Treeby, Zhang, & Cox, 2010) . The key advantages of PAI over pure optical and acoustic imaging methods are: (a) PAI offers a noninvasive, speckle-free (Z. Guo, Li, & Wang, 2009) , and label-free imaging, (b) imaging depth up to~4 cm in vivo (Lin et al., 2018) and~11.6 cm in vitro (Y. Zhou, Wang, Lin, Wang, Chen, & Huang, 2016) have been achieved in biological tissues, (c) PAI can provide anatomical, functional, molecular, metabolic, genetic contrasts, biomarkers, oxygen metabolism, gene expression, and so on (Chuangsuwanich et al., 2018; D. Das & Pramanik, 2019; Deán-Ben, Gottschalk, Mc Larney, Shoham, & Razansky, 2017; Moothanchery, Seeni, Xu, & Pramanik, 2017; D. Pan et al., 2009; Sivasubramanian, Periyasamy, Dienzo, & Pramanik, 2018) , (d) PAI is a multiscale imaging modality, that is, it can image from cells to whole-organs in humans and small-animal whole-body with consistent contrast (mainly light absorption contrast; L. V. Wang & Hu, 2012 ; L. V. Photoacoustic imaging is usually performed using a nanosecond pulsed laser with wavelength in the ultraviolet (UV), visible, or near-infrared (NIR) depending on the biological molecules to be imaged (G. Hong, Antaris, & Dai, 2017) . When light passes through biological tissues, it will be absorbed by the endogenous biological chromophores (Figure 1 ) such as water, lipids, oxy/deoxyhemoglobin (HbO 2 /Hb), melanin. Therefore, PAI can be used to image these endogenous contrast agents. Due to the strong absorption of light by hemoglobin in the visible region (400-780 nm; Lu & Fei, 2014) , 532 nm was widely used for PAI in the early days mainly for vasculature imaging X. D. Wang, Pang, Ku, Stoica, & Wang, 2003) . Due to strong tissue scattering at shorter wavelengths (UV and Visible), the intensity of light, and hence the PA amplitude decreases exponentially along tissue depth with a decay constant of a few millimeters (G. Ku & Wang, 2005) . In the NIR region (780-2,500 nm; Lu & Fei, 2014) the tissue attenuation and scattering is low; hence these wavelengths are ideal for deep-tissue PAI (He, Song, Qu, & Cheng, 2018; Smith, Mancini, & Nie, 2009 ). The NIR-I window (780-1,100 nm) was extensively investigated for deep-tissue and small animal imaging Kalva, Upputuri, Rajendran, Dienzo, & Pramanik, 2019; K. H. Song, Kim, Cobley, Xia, & Wang, 2009 ; P. K. Upputuri & Pramanik, 2015; Z. Wu et al., 2019; X. Yang, Skrabalak, Li, Xia, & Wang, 2007 ; Y. Zhou, Yao, & Wang, 2016) . Due to the reduced blood absorption in the NIR region, the imaging depth is improved with a small sacrifice in contrast. However, for enhancing the PA contrast further and for applications like targeted molecular imaging, drug delivery, therapy, effective contrast agents are often necessary (C. Kim, Favazza, & Wang, 2010; G. P. Luke, Yeager, & Emelianov, 2012; Sowers & Emelianov, 2018; Weber, Beard, & Bohndiek, 2016) . Several types of nanoparticles based on metal (Y. S. Chen et al., 2010; C. K. Cho, Glaus, Chen, & Xia, 2010; W. Li & Chen, 2015; D. Pan et al., 2010; D. Pan, Pramanik, Wickline, Wang, & Lanza, 2011) , carbon (G. Hong, Diao, Antaris, & Dai, 2015;  J.-W. Kim, Galanzha, Shashkov, Moon, & Zharov, 2009; Lalwani, Cai, Nie, Wang, & Sitharaman, 2013; Toumia et al., 2016) , organic dye (D. Das, Sivasubramanian, Yang, & Pramanik, 2018; Gawale et al., 2017) , semiconducting polymer (S. Huang, Upputuri, Liu, Pramanik, & Wang, 2016; were synthesized and demonstrated for PA imaging in the NIR-I window. Along with nanoparticles, reporter genes (RGs), fluorescent proteins (FPs), dyed droplets were also used as PA contrast agents in the range 400-800 nm (Brunker, Yao, Laufer, & Bohndiek, 2017) . Melanoidin, commonly found in a variety of foods (coffee, bread, and soy sauce), has strong absorption around 420 nm F I G U R E 1 Absorption coefficient of endogenous (intrinsic) tissue chromophores at their typical concentrations in the human body as a function of wavelength in the 400-1,400 nm region, which covers the UV, visible, near-infrared I (NIR-I), and near-infrared II (NIR-II) windows, respectively. Adapted from http:// omlc.ogi.edu (H.-Y. Wang, Qian, & Yao, 2011) . Glucose-glycine melanoidin (GG-melanoidin) was demonstrated as a PA agent for imaging as well (Lee et al., 2016) . In addition, there are several multimodal contrast agents that show great potential for PA imaging: MPR (magnetic resonance-photoacoustic-Raman) nanoparticles (Kircher et al., 2012) . carbon nanotubes as a contrast agent for photoacoustic and thermoacoustic imaging (Pramanik, Swierczewska, Green, Sitharaman, & Wang, 2009) , and so on.
The performance of PAI can be further improved by moving the excitation window from NIR-I (700-1,000 nm) to NIR-II (1,000-1,400 nm) window (Antaris et al., 2016; Jiang & Pu, 2018; Kenry, Duan, & Liu, 2018; . The NIR-II window offers: (a) more light energy on the tissues surface, this results in deeper light transmission with longer wavelength excitation. For example, the maximum permissible exposure (MPE) at 800 nm is~300 mW/cm 2 and MPE at 1,064 nm is 1,000 mW/cm 2 per pulse according to ANSI (American National Standards Institute) safety limit ("American National Standard for Safe Use of Lasers ANSI Z136. 1-2007 [American National Standards Institute, Inc., 2007 ), (b) reduced tissue scattering, makes the tissue more transparent at longer wavelengths, (c) minimal auto-fluorescence, reduces the background signal in fluorescence imaging. Taking advantage of high MPE, whole body of mouse (L. Li et al., 2017; , rat (L. Li et al., 2017) , and human organs (Lin et al., 2018; Wray, Lin, Hu, & Wang, 2019) were successfully imaged at 1,064 nm with blood as intrinsic contrast. However, the PA signal generated by NIR-II wavelengths is still weak and hence efforts were made to develop contrast agents with strong absorption in NIR-II window based on Inorganic materials (single walled carbon nanotubes , CuS (G. Ku et al., 2012) , Ag nanostructures (Y. S. Chen, Homan, Xu, Frey, & Emelianov, 2012; Homan et al., 2010; G. P. Luke et al., 2013; Sivasubramanian et al., 2017; , metal-organic particles (D. Zhang et al., 2018) , Bi 2 Se 3 nanoplates (Park et al., 2018) ), and organic materials (phosphorous phthalocyanine (Y. , organic charge transfer complex (Z. , semiconducting nanoparticles (B. Guo et al., 2017; Miao & Pu, 2018; J. Wu et al., 2017) ). In this review, we first discuss PA imaging with intrinsic (endogenous) contrast and later, we will focus on the advances in exogenous PA contrast agents synthesized and demonstrated for in vivo PAI in the past few years.
| PAI WITH INTRINSIC (ENDOGENOUS) CONTRAST
Photoacoustic imaging provides structural and functional information of biological tissues with optical contrast and ultrasound spatial resolution. Due to available intrinsic contrast molecules in the body (e.g., hemoglobin), PAI has been widely used to visualize blood vessel structures, blood oxygenation mapping, functional brain imaging, and so on. In this section we will discuss the recent reports on structural and functional imaging of small-animal whole-body and human organs in vivo. 
| In vivo whole-body imaging of small animals
Small animals such as rats, mice, and so on are ideal models for preclinical studies. They play a key role in studying human diseases and their effective treatments using modern medicine (Xia & Wang, 2014) . High-speed whole-body imaging system is always desired to visualize the biological events in real-time. A PAI system based on scanning of a spherical detection array was reported for 3D imaging of whole body of small animals (Fehm, Deán-Ben, Ford, & Razansky, 2016) . The schematic of the experimental set-up for whole-body imaging is given in Figure 2a . A laser beam with 800 nm wavelength in the NIR-I window, 10 ns pulse duration, 100 Hz repetition rate from an optical parametric oscillator (OPO) laser was used to generate PA signals from the mouse body. The 800 nm beam was delivered to the animal through an opening in the center of the matrix array using a fiber bundle. The fluence on the surface of the mouse was about 19 mJ/cm 2 . This is well below the ANSI (American National Standards Institute) limit 25 mJ/cm 2 at 800 nm ("American National Standard for Safe Use of Lasers ANSI Z136. 1-2007 [American National Standards Institute, Inc., 2007 ). The spherical matrix array, consists of 256 individual detection elements. Each detection element has an approximate area of 9 mm 2 and 100% bandwidth around a central frequency of 4 MHz. The time-resolved PA signals generated by each laser pulse were recorded at 256 individual detector locations of the spherical array, sampled by the data acquisition card, and saved to computer for 3D image reconstruction. The system could provide high frame rate 100 frames per second within volumes of up to 1.5 cm 3 and nearly isotropic spatial resolution in the range of 250-500 μm across fields of view covering the entire mouse body. For in vivo imaging, 50 frames were collected at each scanning position and a clustering approach was applied to minimize the effect of heartbeat and respiration on the image quality. Figures 2b-d display the reconstructed volumetric images of the living mouse from different view angles. The major anatomical structures such as left atrium, cardiac ventricles, liver, spleen, thoracic vessels, kidney, spine, brown adipose tissue are labeled with 1-8, respectively. A preclinical system, single-impulse panoramic photoacoustic computer tomography (SIP-PACT) was demonstrated for in vivo whole-body imaging of small animals (mouse and rat) at 1,064 nm (L. Li et al., 2017) . The anatomy of different organs (brain, heart, lungs, liver, spleen, kidney, caecum, F I G U R E 3 (a) 1,064 nm PACT system with latitudinal mode illumination for in vivo imaging of human hand. PACT of blood vasculature of the human hand (b) MAP image, (c) color-encoded depth image. (Reproduced by permission from Wray et al. (2019) ). MAP, maximum amplitude projection; PACT, photoacoustic computer tomography intestine, etc.) of mouse was obtained with intrinsic hemoglobin contrast at 1,064 nm. The whole-body of mouse having trunk width~28 mm, was imaged with high-contrast and high spatial resolution (~125 μm) at an imaging frame rate of 50 Hz. Another PACT system with a compact 1,064 nm Nd:YAG laser was developed and demonstrated for imaging different organs of mouse with a resolution of 1.5 mm (D. Wang et al., 2017) . Brain, liver, and kidney regions were imaged with 10 Hz pulse repetition frequency over 50 s, while the heart region was imaged with 50 Hz over 10 s.
| In vivo imaging of human extremities
Photoacoustic computer tomography was successfully applied for imaging human organs such as breast (Lin et al., 2018) , skin (Schwarz, Aguirre, Omar, & Ntziachristos, 2016) , thyroid (Dima & Ntziachristos, 2016) , hand fingers (Deng & Li, 2016) . Another interesting work, imaging angiographic structures in human extremities, including hands, arms, legs, and feet, was reported using 1,064 nm PACT (Figure 3a ; Wray et al., 2019) . The excitation light has NIR-II wavelength of 1,064 nm, repetition rate of 10 Hz, and pulse duration between 8 and 12 ns. PA signals from hand were acquired within 100 μs using a full-ring ultrasonic transducer array with 512 elements, central frequency of 2.25 MHz, and one-way bandwidth of more than 95%. The in-plane resolution of the system is 255 μm. A volunteer's right hand was imaged using latitudinal mode illumination as shown in Figure 3a . Figure 3b ,c shows the 3D reconstructed maximum amplitude projection and corresponding color-encoded depth-resolved image of the hand. Blood vessels can be visualized starting from the dorsal side of the wrist and ending at the palmar side of the fingers with high contrast at 1,064 nm. With an imaging depth of 1.8 cm on either side, hands, feet, wrist, upper forearm, leg, and bicep were imaged with 1,064 nm while keeping the energy density within the ANSI limit (100 mJ/cm 2 ). This second window PACT system with excitation wavelength 1,064 nm and blood contrast is a promising for clinical diagnosis of vascular diseases. 
| In vivo functional imaging on small animals
Along with structural information, PAI allows multiscale functional imaging with the use of multiple-wavelengths excitation (D. Pan, Kim, Wang, & Lanza, 2013; Rebling et al., 2018) . A photoacoustic probe with AR (acoustic resolution) and OR (optical resolution) mode imaging facility was reported for both structural and functional imaging (W. Liu et al., 2018) . The probe includes two confocally arranged ultrasound transducers ( Figure 4a ) with central frequencies of 20 MHz (low frequency-LF) and 40 MHz (high frequency-HF), respectively. The excitation wavelengths 532 and 640 nm were delivered through the aperture at the center of the ring-shaped focused UST. The axial resolution was 36 μm for OR-HF mode and AR-HF mode, and 72 μm for OR-LF mode and AR-LF mode, determined by the bandwidth of the transducer elements. For OR-HF mode and OR-LF mode, where the light focus was much tighter than the acoustic focus, the lateral resolution was optically determined by the light spot size of 6.9 μm.
The OR modes of the system were used to image the oxygen saturation of hemoglobin (sO 2 ) in the mouse head with the scalp removed and the skull intact. A traditional linear spectral unmixing method (Rebling et al., 2018) was used to quantify the relative concentrations of oxyhemoglobin (HbO 2 ) and deoxyhemoglobin (HbR), based on the different optical absorption spectra of HbO 2 and HbR ( Figure 4b ). Figure 4c ,d shows the measured sO 2 of the mouse brain vasculature at two OR modes. The sO 2 levels are low in both the images, the only difference is that the 20-MHz transducer element provided stronger signals from the mouse cortex than the 40-MHz transducer element. This could be due to the skull's frequency-dependent acoustic attenuation.
The molecular imaging capability of the AR/OR (acoustic resolution/optical resolution) quad system was demonstrated on the live mouse ear. The top and bottom surfaces of the ear were injected with bacteria expressing bacterial phytochrome monomeric NIR FP miRFP670. This FP has strong optical absorption at 640 nm and has very low absorption at 532 nm, whereas hemoglobin has the opposite trend, as shown in Figure 4b . Therefore, miRFP670 expressing bacteria can be identified by comparing the PA signals acquired at 640 and 532 nm. Figure 4e displays the AR-LF (ARlow frequency) image of the mouse ear with miRFP670 signals in red and the blood signals in green. The proteins on both the top and the bottom surfaces of the ear are visible in the AR mode. The cross-sectional B-scan image of the AR-LF mode along the dashed yellow line (in Figure 4e ) is shown in Figure 4f . Here, the top and bottom proteins are identified by the dashed yellow lines. The laser pulse energy used for imaging was 12 μJ. The quad AR/OR system was successfully demonstrated for multiscale morphological, functional, and molecular imaging in the mouse head, leg, and ear in vivo. The high scale flexibility of the system will enable broad applications in preclinical studies.
In the sections above, we discussed the recent applications of PAI using endogenous contrast hemoglobin (HbO 2 and HbR). There are several other biomolecules in the tissues that are used as contrast source for PAI, for example, melanin (Schwarz, Buehler, Aguirre, & Ntziachristos, 2016; Shu, Li, Dong, Sun, & Zhang, 2017) , collagen (P. Wang, Wang, Wang, & Cheng, 2012) , lipid (Sangha, Phillips, & Goergen, 2017; P. Wang et al., 2012) , myoglobin (Lin, Yao, Li, & Wang, 2016) , bilirubin (Y. Zhou, Zhang, Yao, & Wang, 2012) , glucose (Chatni et al., 2012 ; J. J. Yao et al., 2013) , DNA and RNA (D. K. Yao, Maslov, Shung, Zhou, & Wang, 2010) . The advantage of using intrinsic contrast is that we do not F I G U R E 7 Gold plasmonic blackbody (AuPB) for high-contrast photoacoustic imaging: (a) one-pot synthesis of AuPBs, (b) optical absorbance spectra of dopamine and AuPBs at different stages of synthesis; inset: photographs of dopamine solution (left) and AuPB dispersion (right), (c) simulation results of the heat power density inside the AuPBs illuminated by light at 808 and 1,064 nm with same power density 1.0 W/cm 2 , (d) in vivo PA imaging of mouse tumor (highlighted by yellow circles) at 1,064 nm excitation at different times after intravenous injection of 100 μl of AuPBs (μg/ml). (Reproduced with permission from J. Zhou, Jiang, et al. (2018)) need to inject any external contrast agent, which comes with issues such as biodegradability, bio safety, clearance from body, toxicity. However, sometimes intrinsic contrast is not enough for imaging. In such cases it is necessary to use exogenous contrast agent to enhance the imaging contrast. Exogenous contrast also helps in targeted molecular imaging. Another advantage of using exogenous contrast agent is that their absorption peaks can be easily tuned to the wavelength of our need. In the next section we will discuss in detail the advancement of exogenous contrast agent in the recent past.
| PAI WITH EXOGENOUS CONTRAST ANGETS
Researchers have developed exogenous contrast agents to overcome the shortcomings of different endogenous molecules naturally present in the body. The absorption properties of exogenous agents were usually adjusted to NIR region for PAI. Based on their chemical structure, the PA contrast agents are classified in to (a) inorganic materials such as noble metal materials, metal chalcogenide materials, carbon-based nanomaterials, and (b) organic materials such as small molecules, semiconducting polymer nanoparticles. Broadly, inorganic materials show higher photothermal convention efficiency and good photothermal stability. On the other hand, organic materials show good biodegradability and good biocompatibility. In this section, we will discuss the recently reported inorganic and organic materials as contrast agent for PAI. 3.1 | Inorganic materials
| Metallic nanoparticles
In the field of nanomedicine, the role of metal nanoparticles has rapidly grown due to the characteristic properties at the nanoscale. Gold nanostructures were widely used for biomedical applications due to their unique optical and physicochemical properties (Rivera, Ferri, & Marega, 2012) . When the gold (Au) nanostructures are illuminated by a specific light, surface plasmons are generated in the metal nanosystem (Figure 5a ,b). This LSPR (localized surface plasmon resonance) leads to the absorption of the light, whose energy is efficiently converted into heat, pressure, and then acoustic wave detectable by ultrasound transducers. PA spectra of gold nanoparticles of different shapes are shown in Figure 5c . Spherical AuNPs show absorption only in the visible region and hence they can hardly find applications in deep-tissue imaging. On the other hand, Au-nanorods show a characteristic localized surface plasmon along the longitudinal direction of the nanorod, which generates a strong low-energy absorption band. The absorption band of the nanorods can be tuned to the NIR region by adjusting the aspect ratio of the nanorod. Due to strong NIR absorption, Au-nanorods are finding interesting applications in in vivo imaging.
Recently, gold/silver hybrid nanoparticles were demonstrated for PA imaging of bacterial infection. Here, PA imaging was used to effectively trigger and monitor the release of Ag + ions from Au-nanorods (T. Kim, Zhang, Li, Zhang, & Jokerst, 2018) . Ag + ions are a well-known antibacterial agent, and Ag nanoparticles act as a reservoir of these Ag + ions for targeted therapy of bacterial infections. First, the Au-nanorods with strong absorption in NIR were coated with silver (Ag), which decreased their NIR absorption and hence PA signal. Then, the addition of ferricyanide solution (1 mM) resulted in oxidative etching of the silver shell. Thus, the PA signal from Au-nanorods is recovered as the silver is released, and this PA signal offers noninvasive monitoring of localized release of Ag + ions. The synthesis procedure is illustrated in Figure 6a with corresponding TEM images. Photoacoustic ON and OFF behavior of AuNRs, Au/AgNRs, and etched Au/AgNRs was first confirmed with the PA spectra ( Figure 6b ) and in vitro PA imaging (Figure 6c ). Here, AuNRs produced good PA signal (ON), Au/AgNRs produced no PA signal (OFF), and etched Au/AgNRs produced strong PA signal (ON). (Figure 6d ) and later strong PA signal appeared upon the in vivo silver etching (Figure 6e ). The recovered PA contrast indicates the localized release of silver from the Au/Ag nanoparticles. These results prove that the hybrid Au/Ag nanoparticles are a useful theranostic agent for the PA imaging and treatment of bacterial infections.
Another interesting photoacoustic nano-agent, hyperbranched Au-plasmonic blackbodies (AuPBs) of compact sizes (<50 nm), was reported for photothermal therapy and second window PA imaging (J. Zhou, Jiang, et al., 2018) . The schematic of the one-pot synthesis of AuPB, which contained multiple Au nanoparticle assemblies in polydopamine, is shown in Figure 7a . These AuPBs showed very strong and uniform absorption in the entire wavelength range from 400 to 1,350 nm (Figure 7b ). Such strong optical absorption is due to the intraparticle plasmonic coupling effect among branches. Simulation of the electric field reveals that the hyperbranched nanostructure carries optical hot-spots due to strong coupling of the closely spaced branches (Figure 7c ). Electric fields at the joints and gaps inside the superstructure were enhanced by more than two orders of magnitude, resulting in strong localization of heat generation. Here, the heat power density generated by 808 nm (NIR-I) and 1,064 nm (NIR-II) lasers is similar, indicating the comparable photothermal transduction at these two wavelengths. Here, same power density 1.0 W/cm 2 was used at 808 nm and 1,064 nm. These AuPBs are suitable for PA imaging and photothermal therapy at any wavelength in the range ). HCC, hepatocellular carcinoma; SNR, signal-to-noise ratio 400-1,350 nm. This specific plasmonic Au-nanostructure was successfully demonstrated for tumor imaging on live mouse at 1,064 nm (Figure 7d ). The compact plasmonic broadband nano-agents with tailored surface properties hold potential for a wide spectrum of light-mediated applications.
For clinical translation of AuNPs, their size should be below 10 nm to undergo renal clearance. Due to the direct relationship between their absorption and size, synthesizing small AuNPs for PAI is challenging. Miniature gold nanorods (8 nm × 49 nm) with strong absorption in NIR-II window were synthesized and showed 4.5 times greater photoacoustic contrast on living tumor-bearing mouse at 1,064 nm (Y.-S. Chen, Zhao, Yoon, Gambhir, & Emelianov, 2019 ). An antibody-targeted 5 nm AuNPs were demonstrated as molecularly specific contrast agents for PAI (Han, Bouchard, & Sokolov, 2019) . Copper-based NPs are promising candidates for biological applications due to their good biocompatibility, low cost, and strong absorbance in both NIR-I and NIR-II windows (650-1,300 nm). They can enhance the quantitative accuracy for multispectral PA imaging when the illumination wavelength is over 1,000 nm. Recently, Copper Sulfide (CuS) nanoparticles were demonstrated for deep-tissue and in vivo PA imaging on 4T1 subcutaneous tumor-bearing nude mouse. The CuS NPs showed similar PA amplitudes at 700 nm and 1,050 nm and images obtained at 1,050 nm have 1.5 times higher SNR (signal-to-noise ratio) compared to images at 700 nm (Y. Liu, Gao, Xu, & Yuan, 2019).
| Quantum dots
Optical absorption properties of semiconducting nanoparticles (or quantum dots, QDs) can be easily tuned to the NIR region by choosing the appropriate particle size. They possess high absorption cross-sections, good photostability, and high quantum yield comparable with most small molecule dyes (SMDs). Recently, MoO 3 − x QDs were demonstrated for PA imaging. MoO 3 − x QDs were fabricated via a hydrothermal method in which metallic Mo (molybdenum) and chitosan were used. The chitosan acts as a capping and reducing agent at 80 C for 24 hr. Figure 8a shows the TEM image of the homogeneously dispersed QDs with size around 2.5 nm. HR-TEM images of couple of QDs are shown in (Figure 8c ), such broad absorption comes from the free electron induced LSPR effect. PA images of in vitro phantoms at 880 nm are shown in Figure 8d , here the PA signal from MoO 3 − x QD dispersion linearly increased with its concentration showing its potential for quantitative measurements.
These MoO 3 − x QDs were tested for tumor imaging on live mouse. The HeLa tumor-bearing mice were injected with 100 μl of MoO 3 − x QDs (2 mg/ml) via intratumoral or tail intravenous injection. For the intratumoral injection group shown in Figure 8e , the PA signal from tumor site was increased and the tumor was clearly visible till 24 hr, indicating a long-time accumulation of QDs in the tumor. On the other hand, for the tail intravenous injection group shown in Figure 8f , the strongest PA signal was observed at 4 hr and thereafter the PA signal from tumor decreased slowly and almost vanished after 12 hr. The passive tumor accumulation and clearance after intravenous injection may be due to the small size of QDs (about 2.5 nm). All these results suggest that MoO 3 − x QDs is a promising PA contrast agent for tumor imaging via either intratumoral or intravenous injection. New carbon nanodots, porphyrin-implanted nanodots (PNDs) were developed by selective pyrolysis of porphyrin macrocycles and citric acid (F. Wu et al., 2018) . These PNDs show good aqueous dispersibility, and favorable biocompatibility. The PNDs displayed strong PA signals at 686 nm in a neutral or slightly acidic environment and weaker signals with a pH in a range from 7 to 8. Such carbon NDs can find applications in in vivo photodynamic cancer treatment. Kim, Song, Gao, & Wang, 2010; Koo et al., 2012; Rajian, Fabiilli, Fowlkes, Carson, & Wang, 2011; . It has a concentrationdependent absorption band tunable in the range 700-900 nm; it is water soluble and biocompatible as well. However, ICG suffers from some important drawbacks: poor aqueous stability, concentration-induced aggregation and fast clearance from the body. The fast uptake and clearance of the ICG dye with absorption around 800 nm was monitored in living rat by a pulsed laser diode based PAT (PLD-PAT) system (P. K. Upputuri & Pramanik, 2017a) .
|
Recently, ICG dye was used to label murine bone marrow-derived mesenchymal stem cells, also known as medicinal signaling cells (MSCs; Filippi et al., 2019) . The transplantation of MSCs holds great promise for the treatment of a plethora of human diseases. PAI was used to monitor stem cells labeled with ICG. The labeling procedure was performed by detaching and incubating MSCs with ICG-containing medium at 37 C as shown in Figure 9a . About 3.0 × 10 5 ICG-labeled MSCs were locally transplanted into the gastrocnemius muscle of the right hindlimb of healthy C57BL/6J live mouse. In this study, to distinguish between the signals arising from the intracellular ICG and the free molecule, spectral unmixing was performed on the PA images acquired from right hindlimb as shown in Figure 9b . The PA signal from the intracellular ICG first increased to about 2.5 times with respect to the pre-injection signal, and later became stable for more than 50 hr as shown in Figure 9b . On the other side, the PA signal from free ICG increased after 40 hr, thus suggesting the occurrence of a dye release process. In the PA representative images shown in Figure 9c , the PA signals from intracellular ICG, free ICG, oxyhemoglobin, and deoxyhemoglobin are shown in green, purple, red, and blue colors, respectively. This approach may find applications in transplantation-related studies by providing the in vivo cell fate surveillance with safety and good endogenous contrast among soft tissues.
In parallel, other classes of dyes such as methylene blue, Evans blue, IRdye800, and so on (Laramie, Smith, Marmarchi, McNally, & Henary, 2018) , have been explored as contrast agents for molecular PA imaging. Recently, a new type of small molecular dye-loaded lipid nanoparticles with intense NIR-II absorption was reported for PAI (Q. . Figure 10a illustrates the synthesis procedure in which IR-1061 dyes, CH, and DSPC were first dissolved in dichloromethane for rotary evaporation, and then modified with DSPE-PEG 2000 . More details on these chemicals and reagents are given in Q. . To overcome the inherent hydrophobicity of the IR-1061 dye and expand its use for the biomedical application, Polipo-IR NPs were synthesized by the rotary evaporation method. The F I G U R E 1 3 (a) Schematic of SPN-II nanoparticles, (b) optical absorption spectra of SPN-I and SPN-II (40 μg/ml), in vivo PA images of rat brain at 750 nm (c) and 1,064 nm (d) acquired 70 min after injecting SPN-II (6 mg/ml, 0.3 ml per rat). Energy density used was 5.5 mJ/cm 2 . (Reproduced with permission from ). SPN, semiconducting polymer nanoparticle optical absorbance of Polipo-IR NPs in water and the free IR-1061 dye in CCL 2 are show in Figure 10b . It can be observed that the absorption peak of the Polipo-IR NPs is wider, that is, ranging from 970 to 1,350 nm (NIR-II). The use of Polipo-IR NPs for deep-tissue imaging was demonstrated on chicken tissue phantom (Figure 10c ). This phantom was imaged at two different wavelengths 808 nm (NIR-I) and 1,064 nm (NIR-II). The maximum depth of the phantom was 12.05 mm, and the PA signals of the four phantoms were all obtained using both wavelengths (Figure 10d ). In all four imaged phantoms, the SNRs of 1,064 nm images were superior compared to those of 808 nm (Figure 10e ). All these results confirmed that 1,064 nm is more suitable for deep-tissue imaging than 808 nm.
The NIR-II dye was tested on mice bearing orthotopic HCC (hepatocellular carcinoma). The ultrasound image of the tumor before the administration of Polipo-IR NPs is shown in Figure 10g . Before injection, there was no obvious PA signal in the whole body of mice as shown in Figure 10h . The PA signal of the skin increased at 0.5 hr postinjection, while no strong PA signal appeared in the region of the liver. With the continued circulation of the Polipo-IR NPs in mouse body, two distinct enhanced PA signals appeared in the liver after 2 hr of injection, which was consistent with the corresponding preoperative ultrasound images. The PA signal reached the maximum value at 3 hr postinjection with a maximum SNR of 5.98 ± 0.23 (Figure 10k) , mainly due to the EPR (enhanced permeability and retention) effect and strong PA signal from the Polipo-IR NPs. These results exhibit the great potential of Polipo-IR NPs for in vivo diagnosis of orthotopic HCC and deep-tissue imaging in photoacoustic systems.
| Organic dyed droplets
The spatial resolution of PAT is fundamentally limited by acoustic diffraction. Single dyed droplets that can flow in blood vessels were used to break the acoustic diffraction limit (P. Zhang, Li, Lin, Shi, & Wang, 2019) . The droplets were prepared by dissolving hydrophobic IR-780 iodide dye in oil (67% clove oil + 33% peanut oil), followed by mixing with water. The sizes of the droplets range from 4 to 30 μm, with a mean value of approximately 10 μm. These droplets can flow easily in the blood vessels and can generate PA signal that is two times higher in amplitude compared to the blood. The PACT system was equipped with a full-ring ultrasonic transducer array and a 780 nm excitation laser. The fluence on the mouse head was maintained at 30 mJ/cm 2 . First, the mouse brain was imaged using conventional PACT, where the contrast is due to blood absorption at 780 nm (Figure 11a ). The brain images were continuously acquired, while F I G U R E 1 4 In vivo PA imaging of rat brain vasculature using PIGD NPs: (a) schematic of the synthesis of PIGD nanoparticles, brain vascular images at (b) 0 min (before injection), (c) 40 min, (d) 70 min postinjection of PIGD NPs (2 mg∕ml, 0.25 ml per rat). Energy density used was 5 mJ∕cm 2 . Reproduced with permission from P. K. Upputuri et al. (2018)) droplets were injected into the heart through the catheter. The droplet suspension was prepared with 20 μl of the dye solution (2 mM) in 1 ml of water to achieve a droplet concentration of about 4 × 10 7 ml −1 . Figure 11b shows the superresolution PACT of the brain vasculature due to droplets in the blood stream. The amplitude profiles of conventional and super-resolution images are compared in Figure 11c . In the super-resolution image, the blood vessels appear sharper, and the closely neighboring vessels can be resolved. This dyed droplet technique improved the resolution from 150 to 25 μm, this approach is promising for imaging thin blood vessels and monitoring targeted drug delivery in deep tissues. (Gao, Hu, Liu, Sheng, & Zheng, 2019; Ge et al., 2015; Pramanik et al., 2009) Organic nanomaterials Small organic molecules Ex.: ICG, methylene blue, IR800-dye, Evans blue, and so on (+) Good biocompatibility (+) Low toxicity (−) Fast clearance (−) Short circulation time (−) Poor photostability (Laramie et al., 2018; Y. Liu, Bhattarai, Dai, & Chen, 2019; D. Wu, Huang, Jiang, & Jiang, 2014; Yoo, Jung, Min, Kim, & Lee, 2018) Semiconducting nanoparticles Ex.: Semiconducting polymers, oligomers, and so on (+) Tunable absorption (+) Large absorption coefficient (+) High photostability (+) Low toxicity (+) Size independent optical properties (−) More studies are needed to understand the biodegradation of SPNs (K. Huang, Zhang, Lin, & Huang, 2019; Miao & Pu, 2018; Pu et al., 2015; L. Zhou, Zhou, & Wu, 2018) Abbreviation: SPN, semiconducting polymer nanoparticle.
| Biliverdin nanoparticles
Biodegradable nanoparticles for PAI are rare and limited to a few polymeric nano-agents. The development of biodegradable NPs is important for clinical applications. Metabolically digestible and inherently PAI probes were developed from nanoprecipitation of biliverdin, a naturally occurring heme-based pigment (Fathi et al., 2019) . The synthesis of biliverdin nanoparticles (BVNPs) is shown in Figure 12a . The properties of BVNPs were found to be highly dependent on the nature of the reaction media. Reactions were conducted in water, in 0.1 M 2-(N-morpholino) ethanesulfonic acid (MES) buffer, and in 0.15 M aqueous NaCl solution. The resultant BVNPs are water−BVNPs, MES-BVNPs, and NaCl −BVNPs, respectively. Figure 12b shows the absorption and emission wavelengths of the three different BVNPs. Biodegradable nanoparticles for PAI are rare and limited to a few polymeric nano-agents. The development of biodegradable NPs is important for clinical applications. Metabolically digestible and inherently PAI probes were developed from nanoprecipitation of biliverdin, a naturally occurring heme-based pigment (Fathi et al., 2019) . The synthesis of BVNPs is shown in Figure 12a . The properties of BVNPs were found to be highly dependent on the nature of the reaction media. Reactions were conducted in water, in 0.1 M 2-(N-morpholino) ethanesulfonic acid (MES) buffer, and in 0.15 M aqueous NaCl solution. The resultant BVNPs are water−BVNPs, MES-BVNPs, and NaCl−BVNPs, respectively. Figure 12b shows the absorption and emission wavelengths of the three different BVNPs.
To evaluate the feasibility of using these BVNPs as a diagnostic imaging probe, in vivo experiments were performed on the lymphatic system of mice. Water−BVNPs, MES-BVNPs, NaCl−BVNPs, or a vehicle control was administrated in the hind limb of live mouse via hock injection. No abnormalities were observed in the mouse body due to the injection of the nanoparticles. in vivo PA images of the lymph node and lymphatic vessels at 680 nm are shown in Figure 12c . All three nanoparticle types showed passive accumulation in the lymph nodes. The PA signal intensity was also found to vary with time, indicating a time-dependent nanoparticle uptake and clearance from the lymphatic system. Thus, the BVNPs are promising nano-agents for biocompatible biological imaging due to their inherent photoacoustic and fluorescent properties as well as their complete metabolic digestion.
| Semiconducting polymer nanoparticles
Semiconducting polymer nanoparticles (SPNs) are the advanced organic nano-agents which show several advantages for both fluorescence and PAI compared to the biomaterials discussed above Xie, Upputuri, Zhen, Pramanik, & Pu, 2017) . in vivo brain imaging was demonstrated in NIR-I and NIR-II window using SPNs. The readers can refer to for more details on SPNs having absorption in NIR-I, and SPN-II having broad absorption in NIR-I and NIR-II region. The schematic of SPN-II nanoparticle and optical absorption spectra of SPN-I and SPN-II are shown in Figure 13a ,b, respectively. The SPN-II type nanoparticles showed a spectrum with a maximum peak at 1,253 nm. The SPN-II (6 mg/ml, 300 μl per rat) was injected in rat through intravenous injection. After injection, brain images were acquired using a dual-wavelength PAT scanning system. The system was equipped with a OPO pumped by a Nd:YAG laser. The fundamental of Nd:YAG laser, that is, 1,064 nm (NIR-II) and 750 nm (NIR-I) from OPO were used for imaging. After injection, brain images were acquired at 750 nm up to 70 min. It was measured that PA signals from the blood vessels were increased by 66% and SNR was enhanced by about 1.5-fold after injection. The SNR was stabilized for 70 min, indicating the long-circulation of SPN-II in blood owing to its small diameter (~54 nm) and PEGpassivated surface. For comparison, brain vasculature images at 750 and 1,064 nm are shown in Figure 13c ,d. The SNR at 1,064 nm (27.7 ± 4.1 dB) was 1.5-fold of that at 750 nm (18.2 ± 4.9 dB). These results confirmed the advantage of NIR-II over NIR-I PA imaging.
Another SNPs, ultra-narrow bandgap semiconducting polymer poly(thienoisoindigo-alt-diketopyrrolopyrrole) (denoted as PIGD), were designed and demonstrated for PA imaging at 1,064 nm (P. K. Upputuri et al., 2018) . The synthesis of PIGD is shown in Figure 14a . First, the cerebral cortex of a rat brain was imaged at 1,064 nm using blood as contrast agent. In this case, the vascular contrast at 0 min (before injection) is poor as shown on Figure 14b . After a single injection of PIGD NPs (0.25 ml per rat, 2 mg/ml), brain images were acquired at different time points. The cross-sectional images of the rat brain at 40 and 70 min after injection are shown in Figure 14c,d, respectively . The SNR of the image at 0 and 70 min were 18 and 37 dB, that is, a~twofold enhancement in PA signal due to the accumulation of PIGD NPs in the brain vasculature. The long-circulation of PIGD NPs could be due to their suitable size of~25 nm and the PEGylated surfaces. This in vivo brain imaging proved that even though blood absorption is low at 1,064 nm (NIR-II window), by using suitable long-circulating nano-agents it is possible to achieve high-contrast PA imaging. Several nano-agents demonstrated for small animal brain imaging at 1,064 nm can be found in B. Guo et al. (2018) and P. ). Moreover, using high energy density of 50 mJ/cm 2 at 1,064 nm, the cross-section of relatively large animal (Monkey) brain cortex with skull thickness~2 mm was imaged using blood contrast (X. Yang & Wang, 2008) . With strong 1,064 nm agent, PAT can potentially image through even thicker skull bones. Biomaterial researchers are working on synthesizing biodegradable NIR-II contrast agents based on SPNs for PA imaging .
Along with the novel nanomaterial discussed above, there are voltage-sensitive dyes (VSD; Kang et al., 2019; used for photoacoustically detecting direct neural activities in vivo. Recently another VSD named PAVSD800-2 was demonstrated for monitoring membrane potential for brain imaging (H. K. . Drosophila brain neurons stably express GCaMP5G, a calcium-sensitive FP whose optical absorption coefficient changes with calcium influx during action potentials. PA imaging was used to monitor the odor-evoked neuronal activities in a drosophila model. About~20% odor-evoked fractional PA signal increase was recorded at all depths of the drosophila brain in vivo, with and without removal of the brain cuticle (R. Zhang, Rao, Rong, Raman, & Wang, 2016) .
| CONCLUSIONS AND OUTLOOK
In this review, we briefly discussed the recent developments in the PAI systems, new contrast agents, and their preclinical and clinical applications. Using blood as the endogenous contrast, PAT could image small-animal whole-body including internal organs such as heart, liver, spleen, kidney, spine at high resolution (Fehm et al., 2016; . PAT was also successfully applied for imaging human organs such as whole-breast (Lin et al., 2018) , skin , thyroid gland (Dima & Ntziachristos, 2016) , finger joints (Deng & Li, 2016) , hands, feet, wrist, forearm, leg, bicep (Wray et al., 2019) using blood as the main contrast. In all these applications, blood absorption at 1,064 nm was used to image the anatomy of blood vessels deep inside animal body and human organs. The NIR-II wavelength (1,064 nm) was widely used due to the availability of high MPE of 1,000 mW/cm 2 (about four-time higher than the MPE of 250 mW/cm 2 at 750 nm NIR-I wavelength), and due to reduced blood absorption and tissue scattering in the NIR-II region (P. K. . The high energy 1,064 nm wavelength helped the researchers to quickly realize the potential of PAT for both animal and human imaging applications.
To broaden the applications of PAI modality and to improve the sensitivity, specificity, and contrast of PAI further, several exogenous contrast agents with strong NIR absorption and high photothermal conversion efficiency were developed. We discussed the recently reported PA exogenous contrast agents, such as metallic nanomaterials (Au/Ag (T. Kim et al., 2018) , AuPB (J. Zhou, Jiang, et al., 2018) ), QDs (MoO 3-x ; Ding et al., 2017) , small molecule ICG dye (P. K. Upputuri & Pramanik, 2017a) , IR-1061 dye-loaded lipid NPs (Q. , biodegradable Biliverdin NPs (Fathi et al., 2019) , organic dyed droplets (P. Zhang et al., 2019) , semiconducting polymer nanoparticles (B. Guo et al., 2017; Miao & Pu, 2018; L. Zhou, Zhou, & Wu, 2018) . We classified these PA contrast agents into inorganic and organic materials based on their chemical structure, and summarized their advantages and disadvantages in Table 1 . Semiconducting polymer nanoparticles are the advanced biomaterials which show good optical properties for in vivo PA imaging in recent years.
Ideally, the contrast agents should be nontoxic while in the body, and then completely cleared. Toxicity factor of NPs is a very important concern and toxic effect should be eliminated. The toxicity of inorganic NPs is a critical issue that might hinder their application in biomedical imaging. In general, it is thought that organic nanoparticles are less toxic than inorganic ones, because they are often fully digested within the human GIT (gastrointestinal tract) and are not bio-persistent. Nevertheless, there may be certain circumstances where they could cause toxicity. The toxicity of inorganic and organic NPs are broadly discussed in Cho et al. (2010) and McClements and Xiao (2017) .
All these exciting studies show the potential of PAI for animal and human imaging. However, conventional PAI (with endogenous agents) has few fundamental and technological challenges: (a) the blood absorption and hence the PA signal is weak in the NIR region, which can be somewhat compensated by using high energy light illumination. But the energy of some of the commercial NIR lasers are still not enough to fully utilize the MPE limit permitted by ANSI safety standards. (b) The depth-dependent light attenuation and intermixing of unwanted background signals impose great challenges in the accurate quantification of biological parameters by PAI in vivo, such as pH value in tumors. (c) Thick bone penetration for imaging of brain tumors and imaging of air-filled cavities such as imaging of lung tumors are still challenging. (d) Due to high blood volume in the liver, imaging tumor inside liver is not straight forward.
(e) The large variations in the tissue transmission across different organs at different wavelengths, makes it difficult to carry out quantitative imaging. Numerous exogenous contrast agents have been reported to enhance the performance of conventional PAI. However, there are several challenges and improvements needed before PA agents can be translated into clinical applications: (a) biomaterial studies mostly focus on developing nanomaterials with low quantum yield to enhance their PA efficiency as a contrast agent. But the major focus should be on the elucidation of the biocompatibility, and long-term toxicological profile which are crucial for medical applications. (b) The ratiometric studies show that there is a trade-off between the drug dose and PA signal enhancement. So, the emerging PA contrast agents should be able to provide contrast enhancement even at low concentrations for effective clinical application. (c) All the developed nanomaterials were tested only in proof-of-concept applications such as lymph node imaging, cancer imaging, brain tumor imaging, and so on, in small animals. (d) PA contrast agents with excellent biocompatibility, favorable clearance profiles, and low toxicity similar to those of the clinically approved SMDs (ICG, methylene blue, Evans blue), are still needed. The SMDs show low toxicity, but they are not considered ideal candidates for imaging applications due to their poor photostability and fast clearance. (e) Semiconducting polymer nanoparticles show high photostability, photothermal conversion efficiency, low toxicity, but more studies are needed to understand the biodegradability of SPNs in the body. Recently, metabolizable semiconducting polymer nanoparticles were synthesized and were tested on small animals for brain and tumor imaging at 1,064 nm . More in vivo studies in realistic animal models are needed in this direction.
